Press "esc" to clear
Go to Advanced Search

Showing results

4150 of 1456
20149161354540lauravolpicellipicturejpg.jpg

Article ID: 694381

Untangling Brain Neuron Dysfunction in Parkinson’s Disease and Dementia with Lewy Bodies

University of Alabama at Birmingham

Researchers describe changes in hippocampal neurons early after pathogenic alpha-synuclein aggregates begin to appear. This understanding could point to novel therapeutic treatments to prevent or reverse neuronal defects and halt development of dementia.

Released:
10-May-2018 3:30 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
LizandEvawithmodel.jpg
  • Embargo expired:
    10-May-2018 2:00 PM EDT

Article ID: 694318

Tau-Tolly Microtubular!

Lawrence Berkeley National Laboratory

Structural model of physiological tau-microtubule interactions sheds light on neurological diseases that correlate with their disruption

Released:
10-May-2018 1:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
20180430_episodic_memory_lab_ER_010.JPG

Article ID: 694347

IU Scientists Find First Evidence Animals Can Mentally Replay Past Events

Indiana University

The ability to test human types of memory in animals will strengthen the search for drugs to treat Alzheimer's disease.

Released:
10-May-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Social and Behavioral Sciences

V1.3imageforNN-Chip.jpg
  • Embargo expired:
    9-May-2018 2:00 PM EDT

Article ID: 694247

Lab-on-a-Chip Device Mimics Eye Damage Due to Intense Light

Houston Methodist

Houston Methodist researchers developed a new lab-on-a-chip technology that could quickly screen possible drugs to repair damaged neuron and retinal connections, like what is seen in people with macular degeneration or who’ve had too much exposure to the glare of electronic screens.

Released:
8-May-2018 6:30 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
HE019_20x_Syn1Tuj1_2.jpg
  • Embargo expired:
    9-May-2018 1:00 PM EDT

Article ID: 694273

The Joy of Neurons: A Simplified 'Cookbook' for Engineering Brain Cells to Study Disease

Scripps Research Institute

The new research opens the door to studying common brain conditions such as autism, schizophrenia, addiction and Alzheimer’s disease under reproducible conditions in a dish.

Released:
9-May-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
fibrils_graphene_final_900.jpg

Article ID: 694279

SLAC’s X-ray Laser Opens New View on Proteins Related to Alzheimer’s Disease

SLAC National Accelerator Laboratory

An international research team has come up with a new method with potential for revealing the structure of individual amyloid fibrils with powerful beams of X-ray laser light.

Released:
9-May-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 694171

Study Provides Robust Evidence of Sex Differences with Alzheimer’s Gene

Vanderbilt University Medical Center

The APOE gene, the strongest genetic risk factor for Alzheimer’s disease, may play a more prominent role in disease development among women than men, according to new research from the Vanderbilt Memory and Alzheimer’s Center.

Released:
7-May-2018 4:25 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
ProMedica-UTNeurosciencesCenterExterior2.jpg

Article ID: 694087

ProMedica and The University of Toledo College of Medicine and Life Sciences Open $57 Million Joint Neurosciences Center

ProMedica

The new 122,000-square-foot, three-story Neurosciences Center provides a highly collaborative environment for clinical care, research and academic services related to neurological disorders and diseases.

Released:
4-May-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
nSMAse2_cambinol.jpg

Article ID: 693903

How a Small Molecule Halts the Spread of a Toxic Protein Associated with Alzheimer’s Progression

UCLA School of Nursing

Researchers at the UCLA School of Nursing and the department of neurology at the David Geffen School of Medicine at UCLA have reported a promising drug strategy that blocks tau transmission. The study was published online in the journal Biochemical and Biophysical Research Communications.

Released:
2-May-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 693854

NeuroVision Announces a $15 Million Series C Financing with a first close of $11.2 Million

NeuroVision

NeuroVision Imaging Inc. has announced a Series C financing round of $15 million with an initial close of $11.2 million. The round is led by Wildcat Capital Management with funding from several new investment groups. The financing provides support for NeuroVision as it seeks validation and regulatory approval for its breakthrough, low-cost, noninvasive, eye imaging system for measuring retinal autofluorescence that can detect amyloid beta (Aβ) plaque in the eye.

Released:
2-May-2018 6:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

4150 of 1456





Chat now!